Piezo1 activation using Yoda1 inhibits macropinocytosis in A431 human epidermoid carcinoma cells

Sci Rep. 2022 Apr 15;12(1):6322. doi: 10.1038/s41598-022-10153-8.

Abstract

Macropinocytosis is a type of endocytosis accompanied by actin rearrangement-driven membrane deformation, such as lamellipodia formation and membrane ruffling, followed by the formation of large vesicles, macropinosomes. Ras-transformed cancer cells efficiently acquire exogenous amino acids for their survival through macropinocytosis. Thus, inhibition of macropinocytosis is a promising strategy for cancer therapy. To date, few specific agents that inhibit macropinocytosis have been developed. Here, focusing on the mechanosensitive ion channel Piezo1, we found that Yoda1, a Piezo1 agonist, potently inhibits macropinocytosis induced by epidermal growth factor (EGF). The inhibition of ruffle formation by Yoda1 was dependent on the extracellular Ca2+ influx through Piezo1 and on the activation of the calcium-activated potassium channel KCa3.1. This suggests that Ca2+ ions can regulate EGF-stimulated macropinocytosis. We propose the potential for macropinocytosis inhibition through the regulation of a mechanosensitive channel activity using chemical tools.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport
  • Calcium / metabolism
  • Carcinoma, Squamous Cell*
  • Cell Line, Tumor
  • Epidermal Growth Factor* / pharmacology
  • Humans
  • Ion Channels* / agonists
  • Ion Channels* / metabolism
  • Pinocytosis / drug effects
  • Pyrazines*
  • Thiadiazoles*

Substances

  • Ion Channels
  • PIEZO1 protein, human
  • Pyrazines
  • Thiadiazoles
  • yoda-1
  • Epidermal Growth Factor
  • Calcium